FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes Print this page SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50 mg capsules as an… Read More »
She has answered numerous questions over the anorexia year with professional efficiency. Learn more about this accreditation here. We take each room request like, depending on our availability and your preference. You will meet with a number treatment key people on your first day, including the following. The therapist will help you: whwt with your… Read More »
A new study finds a lower risk of adverse post-treatment outcomes among returning military service personnel with chronic pain who received nondrug therapy. Share on PinterestNew research shows that some nondrug therapies, including exercise therapy, can help relieve pain in veterans. Many people returning from military deployment experience physical and mental health issues. These can… Read More »
More than a thousand scientists have built the most detailed picture of cancer ever in a landmark study. They said cancer was like a 100,000-piece jigsaw, and that until today, 99% of the pieces were missing. Their studies, published in the journal Nature, provide an almost complete picture of all cancers. They could allow treatment… Read More »